Literature DB >> 15381760

The nuclear envelope and human disease.

Antoine Muchir1, Howard J Worman.   

Abstract

Mutations in nuclear lamins A and C, intermediate filament proteins of the nuclear envelope, cause diseases affecting various tissues and the aging process. We review what is known about nuclear lamin function and the different diseases caused by mutations in lamins A and C and associated inner nuclear membrane proteins.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15381760     DOI： 10.1152/physiol.00022.2004

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN： 1548-9221


  25 in total

Review 1.  The nuclear envelope.

Authors:  Martin W Hetzer
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 2.  Emery-Dreifuss muscular dystrophy.

Authors:  Antoine Muchir; Howard J Worman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

3.  Proteasome-mediated degradation of integral inner nuclear membrane protein emerin in fibroblasts lacking A-type lamins.

Authors:  Antoine Muchir; Catherine Massart; Baziel G van Engelen; Martin Lammens; Gisèle Bonne; Howard J Worman
Journal:  Biochem Biophys Res Commun       Date:  2006-11-03       Impact factor: 3.575

Review 4.  The life cycle of the metazoan nuclear envelope.

Authors:  Daniel J Anderson; Martin W Hetzer
Journal:  Curr Opin Cell Biol       Date:  2008-05-19       Impact factor: 8.382

5.  Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.

Authors:  Erin B Harmon; Michelle L Harmon; Tricia D Larsen; Jie Yang; Joseph W Glasford; M Benjamin Perryman
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

Review 6.  Nuclear lamins and neurobiology.

Authors:  Stephen G Young; Hea-Jin Jung; John M Lee; Loren G Fong
Journal:  Mol Cell Biol       Date:  2014-05-19       Impact factor: 4.272

7.  Structural protein 4.1R is integrally involved in nuclear envelope protein localization, centrosome-nucleus association and transcriptional signaling.

Authors:  Adam J Meyer; Donna K Almendrala; Minjoung M Go; Sharon Wald Krauss
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

8.  Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene.

Authors:  Wei Wu; Jian Shan; Gisèle Bonne; Howard J Worman; Antoine Muchir
Journal:  Biochim Biophys Acta       Date:  2010-04-11

9.  Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.

Authors:  Monica P Mallampalli; Gregory Huyer; Pravin Bendale; Michael H Gelb; Susan Michaelis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

10.  Altered Lamin A/C splice variant expression as a possible diagnostic marker in breast cancer.

Authors:  Ahmad Aljada; Joseph Doria; Ayman M Saleh; Shahad H Al-Matar; Sarah AlGabbani; Heba Bani Shamsa; Ahmad Al-Bawab; Altayeb Abdalla Ahmed
Journal:  Cell Oncol (Dordr)       Date:  2016-01-05       Impact factor: 6.730
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.